Frazier Life Sciences Management, L.P. Q2 2022 Filing
Filed August 10, 2022
Portfolio Value
$1.1T
Holdings
41
Report Date
Q2 2022
Filing Type
13F-HR
All Holdings (41 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | ARQTARCUTIS BIOTHERAPEUTICS INC | 8,434,232 | $179.7B | 16.96% | |
| 2 | HLVXHILLEVAX INC | 9,285,682 | $101.5B | 9.58% | |
| 3 | KRYSKRYSTAL BIOTECH INC | 1,095,407 | $71.9B | 6.79% | |
| 4 | MIRMMIRUM PHARMACEUTICALS INC | 3,566,912 | $69.4B | 6.55% | |
| 5 | 290ACHINOOK THERAPEUTICS INC | 3,595,026 | $62.9B | 5.93% | |
| 6 | SNDXSYNDAX PHARMACEUTICALS INC | 3,195,403 | $61.5B | 5.80% | |
| 7 | PHATPHATHOM PHARMACEUTICALS INC | 5,827,415 | $49.2B | 4.64% | |
| 8 | —SIERRA ONCOLOGY INC | 870,636 | $47.9B | 4.52% | |
| 9 | —IMAGO BIOSCIENCES INC | 2,971,274 | $39.8B | 3.75% | |
| 10 | PCVXVAXCYTE INC | 1,787,405 | $38.9B | 3.67% | |
| 11 | CRNXCRINETICS PHARMACEUTICALS IN | 1,414,823 | $26.4B | 2.49% | |
| 12 | TARSTARSUS PHARMACEUTICALS INC | 1,787,527 | $26.1B | 2.46% | |
| 13 | NVLSEURALPINE IMMUNE SCIENCES INC | 2,985,757 | $25.4B | 2.40% | |
| 14 | 1T7TRICIDA INC | 2,082,093 | $20.2B | 1.90% | |
| 15 | COGTCOGENT BIOSCIENCES INC | 2,094,154 | $18.9B | 1.78% | |
| 16 | ANABANAPTYSBIO INC | 899,700 | $18.3B | 1.72% | |
| 17 | GRCLGRACELL BIOTECHNOLOGIES INC | 3,111,551 | $17.1B | 1.62% | |
| 18 | KALVKALVISTA PHARMACEUTICALS INC | 1,572,192 | $15.5B | 1.46% | |
| 19 | MRUSMERUS N V | 673,979 | $15.3B | 1.44% | |
| 20 | —FRAZIER LIFESCIENCES ACQU CO | 1,501,000 | $14.8B | 1.40% | |
| 21 | REPLREPLIMUNE GROUP INC | 806,267 | $14.1B | 1.33% | |
| 22 | 2JQGRITSTONE BIO INC | 5,237,348 | $12.7B | 1.20% | |
| 23 | ARVNARVINAS INC | 285,331 | $12.0B | 1.13% | |
| 24 | PASGPASSAGE BIO INC | 5,009,219 | $11.8B | 1.12% | |
| 25 | VRDNVIRIDIAN THERAPEUTICS INC | 980,302 | $11.3B | 1.07% | |
| 26 | AUTLAUTOLUS THERAPEUTICS PLC | 3,746,857 | $10.6B | 1.00% | |
| 27 | NTLAINTELLIA THERAPEUTICS INC | 203,684 | $10.5B | 0.99% | |
| 28 | SLNSILENCE THERAPEUTICS PLC | 881,173 | $10.4B | 0.99% | |
| 29 | TYRATYRA BIOSCIENCES INC | 1,375,065 | $9.8B | 0.93% | |
| 30 | STROSUTRO BIOPHARMA INC | 1,776,479 | $9.3B | 0.87% | |
| 31 | ACRSACLARIS THERAPEUTICS INC | 408,329 | $5.7B | 0.54% | |
| 32 | CERE1EURCEREVEL THERAPEUTICS HLDNG I | 202,260 | $5.3B | 0.50% | |
| 33 | TRVITREVI THERAPEUTICS INC | 1,171,627 | $3.3B | 0.31% | |
| 34 | —PARDES BIOSCIENCES INC | 845,636 | $2.6B | 0.24% | |
| 35 | IMVTIMMUNOVANT INC | 585,759 | $2.3B | 0.22% | |
| 36 | EPIEURESSA PHARMA INC | 692,910 | $2.2B | 0.21% | |
| 37 | OPHTEURIVERIC BIO INC | 170,000 | $1.6B | 0.15% | |
| 38 | —MOLECULAR TEMPLATES INC | 1,374,047 | $1.3B | 0.12% | |
| 39 | —EPIZYME INC | 739,369 | $1.1B | 0.10% | |
| 40 | —APTINYX INC | 1,883,244 | $1.1B | 0.10% | |
| 41 | —NABRIVA THERAPEUTICS PLC | 425,650 | $77.0M | 0.01% |